# Safety and Efficacy on Deoxyspergualin (NKT-01) in Patients With Lupus Nephritis

> **NCT00709722** · PHASE1,PHASE2 · COMPLETED · sponsor: **Nippon Kayaku Co., Ltd.** · enrollment: 21 (actual)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** NKT-01

## Key facts

- **NCT ID:** NCT00709722
- **Lead sponsor:** Nippon Kayaku Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2017-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00709722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00709722, "Safety and Efficacy on Deoxyspergualin (NKT-01) in Patients With Lupus Nephritis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00709722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*